Mast cells play an important role in Chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3840-3851

  Chiba, Norika ^a   Shimada, Kenichi ^a   Chen, Shuang ^a   Jones, Heather D ^a   Alsabeh, Randa ^b   Slepenkin, Anatoly V ^c   Peterson, Ellena ^c   Crother, Timothy R ^a   Arditi, Moshe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 18; CLAUDIN 5; COMPOUND 48-80; CROMOGLYCATE DISODIUM; GELATINASE B; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; 4 METHOXY N METHYLPHENETHYLAMINE; ANTIASTHMATIC AGENT; MMP9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL LOAD; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CHLAMYDIAL PNEUMONIA; CONTROLLED STUDY; LUNG LAVAGE; LYMPHOCYTE MIGRATION; MACROPHAGE MIGRATION; MAST CELL; MAST CELL DEGRANULATION; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY TRACT INFLAMMATION; TIGHT JUNCTION; ANIMAL; BACTERIAL PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOTION; CHLAMYDIA PNEUMONIAE; CHLAMYDOPHILA INFECTION; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTI-ASTHMATIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CROMOLYN SODIUM; HUMANS; MAST CELLS; MATRIX METALLOPROTEINASE 9; MICE; MICE, TRANSGENIC; P-METHOXY-N-METHYLPHENETHYLAMINE; PNEUMONIA, BACTERIAL; PROTEOLYSIS;

EID: 84927643719     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402685     Document Type: Article

References (66)

1. Kuo, C.-C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
2. Teh, B., M. L. Grayson, P. D. R. Johnson, and P. G. P. Charles. 2012. Doxycycline vs. macrolides in combination therapy for treatment of communityacquired pneumonia. Clin. Microbiol. Infect. 18:E71-E73.
3. Sutherland, E. R., and R. J. Martin. 2007. Asthma and atypical bacterial infection. Chest 132:1962-1966.
4. Watson, C., and N. J. Alp. 2008. Role of Chlamydia pneumoniae in atherosclerosis. Clin. Sci. 114:509-531.
5. Naiki, Y., R. Sorrentino, M. H. Wong, K. S. Michelsen, K. Shimada, S. Chen, A. Yilmaz, A. Slepenkin, N. W. J. Schröder, T. R. Crother, et al. 2008. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J. Immunol. 181:7176-7185.
6. Schröder, N. W., T. R. Crother, Y. Naiki, S. Chen, M. H. Wong, A. Yilmaz, A. Slepenkin, D. Schulte, R. Alsabeh, T. M. Doherty, et al. 2008. Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. J. Allergy Clin. Immunol. 122:595, e5.
7. Grayston, J. T. 2000. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis. 181 (Suppl. 3):S402-S410.
8. Naiki, Y., K. S. Michelsen, N. W. Schröder, R. Alsabeh, A. Slepenkin, W. Zhang, S. Chen, B. Wei, Y. Bulut, M. H. Wong, et al. 2005. MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. J. Biol. Chem. 280:29242-29249.
9. Rodriguez, N., N. Wantia, F. Fend, S. Dürr, H. Wagner, and T. Miethke. 2006. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae. Eur. J. Immunol. 36:1145-1155.
10. Shimada, K., S. Chen, P. W. Dempsey, R. Sorrentino, R. Alsabeh, A. V. Slepenkin, E. Peterson, T. M. Doherty, D. Underhill, T. R. Crother, and M. Arditi. 2009. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog. 5:e1000379.
11. Shimada, K., T. R. Crother, and M. Arditi. 2012. Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect. 14:1301-1307.
12. Dietrich, N., M. Rohde, R. Geffers, A. Kröger, H. Hauser, S. Weiss, and N. O. Gekara. 2010. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc. Natl. Acad. Sci. USA 107:8748-8753.
13. He, X., S. Mekasha, N. Mavrogiorgos, K. A. Fitzgerald, E. Lien, and R. R. Ingalls. 2010. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J. Immunol. 184:5743-5754.
14. Shimada, K., T. R. Crother, J. Karlin, S. Chen, N. Chiba, V. K. Ramanujan, L. Vergnes, D. M. Ojcius, and M. Arditi. 2011. Caspase-1 dependent IL-1b secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS ONE 6:e21477.
15. Graham, A. C., K. M. Hilmer, J. M. Zickovich, and J. J. Obar. 2013. Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J. Immunol. 190:4676-4684.
16. Rodriguez, N., F. Fend, L. Jennen, M. Schiemann, N. Wantia, C. U. Prazeres Da Costa, S. Dürr, U. Heinzmann, H. Wagner, and T. Miethke. 2005. Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J. Immunol. 174:4836-4844.
17. Crother, T. R., J. Ma, M. Jupelli, N. Chiba, S. Chen, A. Slepenkin, R. Alsabeh, E. Peterson, K. Shimada, and M. Arditi. 2012. Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS ONE 7:e48655.
18. Oksaharju, A., J. Lappalainen, A. M. Tuomainen, P. J. Pussinen, M. Puolakkainen, P. T. Kovanen, and K. A. Lindstedt. 2009. Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J. Cell. Mol. Med. 13:103-113.
19. Christy, A. L., M. E. Walker, M. J. Hessner, and M. A. Brown. 2013. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J. Autoimmun. 42:50-61.
20. Nakamura, Y., N. Kambe, M. Saito, R. Nishikomori, Y. G. Kim, M. Murakami, G. Núñez, and H. Matsue. 2009. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J. Exp. Med. 206:1037-1046.
21. Matsuguchi, T. 2012. Mast cells as critical effectors of host immune defense against Gram-negative bacteria. Curr. Med. Chem. 19:1432-1442.
22. Urb, M., and D. C. Sheppard. 2012. The role of mast cells in the defence against pathogens. PLoS Pathog. 8:e1002619.
23. Rottenberg, M. E., A. Gigliotti-Rothfuchs, and H. Wigzell. 2002. The role of IFN-gamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 14:444-451.
24. Lê, B. V., H. Khorsi-Cauet, V. Bach, and J. Gay-Quéheillard. 2012. Mast cells mediate Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation in rat. Eur. J. Clin. Microbiol. Infect. Dis. 31:1983-1990.
25. Rodriguez, A. R., J.-J. Yu, M. N. Guentzel, C. S. Navara, K. E. Klose, T. G. Forsthuber, J. P. Chambers, M. T. Berton, and B. P. Arulanandam. 2012. Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis. J. Immunol. 188:5604-5611.
26. Dudeck, A., C. A. Suender, S. L. Kostka, E. Von Stebut, and M. Maurer. 2011. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur. J. Immunol. 41:1883-1893.
27. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77.
28. Xu, X., D. Zhang, N. Lyubynska, P. J. Wolters, N. P. Killeen, P. Baluk, D. M. McDonald, S. Hawgood, and G. H. Caughey. 2006. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 173:219-225.
29. Ketavarapu, J. M., A. R. Rodriguez, J.-J. Yu, Y. Cong, A. K. Murthy, T. G. Forsthuber, M. N. Guentzel, K. E. Klose, M. T. Berton, and B. P. Arulanandam. 2008. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc. Natl. Acad. Sci. USA 105:9313-9318.
30. Klesney-Tait, J., K. Keck, X. Li, S. Gilfillan, K. Otero, S. Baruah, D. K. Meyerholz, S. M. Varga, C. J. Knudson, T. O. Moninger, et al. 2013. Transepithelial migration of neutrophils into the lung requires TREM-1. J. Clin. Invest. 123:138-149.
31. Vartio, T., H. Seppä, and A. Vaheri. 1981. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J. Biol. Chem. 256:471-477.
32. Caughey, G. H. 2007. Mast cell tryptases and chymases in inflammation and host defense. Immunol. Rev. 217:141-154.
33. Fang, K. C., W. W. Raymond, S. C. Lazarus, and G. H. Caughey. 1996. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97:1589-1596.
34. Tchougounova, E., A. Lundequist, I. Fajardo, J.-O. Winberg, M. Å Brink, and G. Pejler. 2005. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280:9291-9296.
35. Parks, W. C., and S. D. Shapiro. 2001. Matrix metalloproteinases in lung biology. Respir. Res. 2:10-19.
36. Oyamada, S., C. Bianchi, S. Takai, L. M. Chu, and F. W. Sellke. 2011. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. J. Pharmacol. Exp. Ther. 339:143-151.
37. Bradley, L. M., M. F. Douglass, D. Chatterjee, S. Akira, and B. J. G. Baaten. 2012. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog. 8:e1002641.
38. Wang, F., B. Daugherty, L. L. Keise, Z. Wei, J. P. Foley, R. C. Savani, and M. Koval. 2003. Heterogeneity of claudin expression by alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 29:62-70.
39. Ichiyasu, H., J. M. McCormack, K. M. McCarthy, D. Dombkowski, F. I. Preffer, and E. E. Schneeberger. 2004. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell Mol. Biol. 30:761-770.
40. Chiu, P.-S., and S.-C. Lai. 2013. Matrix metalloproteinase-9 leads to claudin-5 degradation via the NF-kB pathway in BALB/c mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. PLoS ONE 8:e53370.
41. Armstrong, S. M., C. Wang, J. Tigdi, X. Si, C. Dumpit, S. Charles, A. Gamage, T. J. Moraes, and W. L. Lee. 2012. Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5. PLoS ONE 7:e47323.
42. Ohta, H., S. Chiba, M. Ebina, M. Furuse, and T. Nukiwa. 2012. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 302:L193-L205.
43. Rodewald, H.-R., and T. B. Feyerabend. 2012. Widespread immunological functions of mast cells: fact or fiction? Immunity 37:13-24.
44. Tunis, M. C., W. Dawicki, K. R. Carson, J. Wang, and J. S. Marshall. 2012. Mast cells and IgE activation do not alter the development of oral tolerance in a murine model. J. Allergy Clin. Immunol. 130:705-715.
45. Piconese, S., M. Costanza, S. Musio, C. Tripodo, P. L. Poliani, G. Gri, A. Burocchi, P. Pittoni, A. Gorzanelli, M. P. Colombo, and R. Pedotti. 2011. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice. Lab. Invest. 91:627-641.
46. Peterson, E. M., G. M. Zhong, E. Carlson, and L. M. De La Maza. 1988. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect. Immun. 56:885-891.
47. Mancardi, D. A., F. Jönsson, B. Iannascoli, H. Khun, N. Van Rooijen, M. Huerre, M. Daëron, and P. Bruhns. 2011. Cutting Edge: The murine high-affinity IgG receptor FcgRIV is sufficient for autoantibody-induced arthritis. J. Immunol. 186:1899-1903.
48. Chiba, N., A. Masuda, Y. Yoshikai, and T. Matsuguchi. 2007. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells. J. Cell. Physiol. 213:126-136.
49. Blasi, F., S. Centanni, and L. Allegra. 2004. Chlamydia pneumoniae: crossing the barriers? Eur. Respir. J. 23:499-500.
50. Cheng, L. E., K. Hartmann, A. Roers, M. F. Krummel, and R. M. Locksley. 2013. Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity 38:166-175.
51. Föger, N., A. Jenckel, Z. Orinska, K.-H. Lee, A. C. Chan, and S. Bulfone-Paus. 2011. Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b. J. Exp. Med. 208:1777-1787.
52. Zsámboki, G. 1994. The pharmacology of sodium cromoglycate. Ther. Hung. 42:37-40.
53. Gieffers, J., G. Van Zandbergen, J. Rupp, F. Sayk, S. Krüger, S. Ehlers, W. Solbach, and M. Maass. 2004. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur. Respir. J. 23:506-510.
54. Koibuchi, Y., A. Ichikawa, M. Nakagawa, and K. Tomita. 1985. Histamine release induced from mast cells by active components of compound 48/80. Eur. J. Pharmacol. 115:163-170.
55. Kanbe, N., A. Tanaka, M. Kanbe, A. Itakura, M. Kurosawa, and H. Matsuda. 1999. Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29:2645-2649.
56. Tanaka, A., K. Arai, Y. Kitamura, and H. Matsuda. 1999. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 94:2390-2395.
57. Katz, H. R., and K. F. Austen. 2011. Mast cell deficiency, a game of kit and mouse. Immunity 35:668-670.
58. Seeley, E. J., R. E. Sutherland, S. S. Kim, and P. J. Wolters. 2011. Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice. J. Leukoc. Biol. 90:591-597.
59. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNFalpha. Nature 381:77-80.
60. Tate, M. D., A. G. Brooks, and P. C. Reading. 2011. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol. Cell Biol. 89:482-491.
61. Van Den Boogaard, F. E., X. Brands, J. J. Roelofs, R. De Beer, O. J. De Boer, C. Van't Veer, and T. Van Der Poll. 2014. Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia. J. Infect. Dis. 210:1376-1384.
62. Rupp, J., L. Pfleiderer, C. Jugert, S. Moeller, M. Klinger, K. Dalhoff, W. Solbach, S. Stenger, T. Laskay, and G. Van Zandbergen. 2009. Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages. PLoS ONE 4:e6020.
63. Van Zandbergen, G., J. Gieffers, H. Kothe, J. Rupp, A. Bollinger, E. Aga, M. Klinger, H. Brade, K. Dalhoff, M. Maass, et al. 2004. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J. Immunol. 172:1768-1776.
64. Masure, S., P. Proost, J. Van Damme, and G. Opdenakker. 1991. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198:391-398.
65. Opdenakker, G., P. E. Van Den Steen, and J. Van Damme. 2001. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22:571-579.
66. Reber, L. L., T. Marichal, and S. J. Galli. 2012. New models for analyzing mast cell functions in vivo. Trends Immunol. 33:613-625.